Notice of Shareholding
December 20 2007 - 5:44AM
UK Regulatory
RNS Number:3652K
Arana Therapeutics Limited
20 December 2007
For Immediate Release 20 December 2007
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer has identified on 20 December 2007 that with effect from 19
December 2007 the following changes in its share register
(a) Citicorp Nominees Pty Limited reduced its direct holding from 14,698,834
(6.26% % of the issued share capital of the Company) ordinary shares in the
capital of the Company to 3,868,689 (1.65% of the issued share capital of the
Company) ordinary shares in the capital of the Company; and
(b) Rockwell Securities Limited increased its holding by 10,926,884 ordinary
shares to 10,997,103 (4.68% of the issued share capital of the Company) ordinary
shares in the capital of the Company.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLTMBMTMMITBMR
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From May 2024 to Jun 2024
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From Jun 2023 to Jun 2024